ESC Premium Access

In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability

Congress Presentation

About the speaker

Professor Ingegerd Ostman-Smith

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)
0 follower

5 more presentations in this session

Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.

Speaker: Doctor C. Fumagalli (Florence, IT)


Survival after septal myectomy in male and female patients with hypertrophic obstructive cardiomyopathy

Speaker: Mr R. Huurman (Rotterdam, NL)


Myocardial transit time (MTT) - a novel and easy-to-perform CMR parameter to assess microvascular disease.

Speaker: Mr G. Chatzantonis (Munster, DE)


FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

Speaker: Doctor F. Ader (Paris, FR)


Characteristics and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy

Speaker: Doctor K. Choi (Seoul, KR)


Access the full session

Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Speakers: Professor I. Ostman-Smith, Doctor C. Fumagalli, Mr R. Huurman, Mr G. Chatzantonis, Doctor F. Ader...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb